Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
After Sarepta Reversed Course On Elevidys, Could An Adcomm Be Next?
Jul 22 2025
•
By
Derrick Gingery
and
Mandy Jackson
Shipments to non-ambulatory DMD patients already are paused, but now Elevidys will not be shipped to ambulatory boys.
(Shutterstock)
More from Post-Marketing Regulation & Studies
More from United States